Human iPSC-Derived Neural Crest Stem Cells Exhibit Low Immunogenicity

Recent clinical trials are evaluating induced pluripotent stem cells (iPSCs) as a cellular therapy in the field of regenerative medicine. The widespread clinical utility of iPSCs is expected to be realized using allogeneic cells that have undergone thorough safety evaluations, including assessment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehler, Vera J., Burns, Chris J., Stauss, Hans, Francis, Robert J., Moore, Melanie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005462/
https://www.ncbi.nlm.nih.gov/pubmed/32055644
http://dx.doi.org/10.1016/j.omtm.2019.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005462/
https://www.ncbi.nlm.nih.gov/pubmed/32055644
http://dx.doi.org/10.1016/j.omtm.2019.12.015

Ejemplares similares